home / stock / smfr / smfr quote
Last: | $0.3106 |
---|---|
Change Percent: | -4.45% |
Open: | $0.2559 |
Close: | $0.3106 |
High: | $0.3306 |
Low: | $0.2534 |
Volume: | 4,704,920 |
Last Trade Date Time: | 01/09/2023 03:40:58 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.3106 | $0.2559 | $0.3106 | $0.3306 | $0.2534 | 4,704,920 | 01-09-2023 |
$0.245 | $0.2515 | $0.245 | $0.2585 | $0.2349 | 1,404,607 | 01-06-2023 |
$0.2446 | $0.26 | $0.2446 | $0.2691 | $0.2416 | 1,448,666 | 01-05-2023 |
$0.2571 | $0.28 | $0.2571 | $0.2994 | $0.255 | 2,076,757 | 01-04-2023 |
$0.2797 | $0.27 | $0.2797 | $0.2887 | $0.243 | 2,209,876 | 01-03-2023 |
$0.2638 | $0.24 | $0.2638 | $0.28 | $0.2363 | 1,461,028 | 01-02-2023 |
$0.2638 | $0.24 | $0.2638 | $0.28 | $0.2363 | 1,461,028 | 12-30-2022 |
$0.2436 | $0.22 | $0.2436 | $0.2484 | $0.22 | 1,140,361 | 12-29-2022 |
$0.2242 | $0.2451 | $0.2242 | $0.2479 | $0.2229 | 1,215,170 | 12-28-2022 |
$0.235 | $0.25 | $0.235 | $0.25 | $0.2245 | 1,076,302 | 12-27-2022 |
$0.2434 | $0.2541 | $0.2434 | $0.2673 | $0.24 | 808,299 | 12-26-2022 |
$0.2434 | $0.2541 | $0.2434 | $0.267299 | $0.24 | 808,299 | 12-23-2022 |
$0.2556 | $0.26 | $0.2556 | $0.2665 | $0.245 | 1,580,442 | 12-22-2022 |
$0.2623 | $0.2581 | $0.2623 | $0.2743 | $0.251 | 2,158,009 | 12-21-2022 |
$0.2564 | $0.25 | $0.2564 | $0.2657 | $0.2401 | 8,892,095 | 12-20-2022 |
$0.2478 | $0.2642 | $0.2478 | $0.2799 | $0.24 | 2,234,172 | 12-19-2022 |
$0.262 | $0.277 | $0.262 | $0.29 | $0.2576 | 5,550,536 | 12-16-2022 |
$0.2803 | $0.2963 | $0.2803 | $0.305 | $0.2743 | 1,790,535 | 12-15-2022 |
$0.2975 | $0.2923 | $0.2975 | $0.3088 | $0.2814 | 1,527,724 | 12-14-2022 |
$0.2896 | $0.2937 | $0.2896 | $0.32 | $0.2838 | 2,318,720 | 12-13-2022 |
News, Short Squeeze, Breakout and More Instantly...
Sema4 Holdings Corp. Company Name:
SMFR Stock Symbol:
NASDAQ Market:
Company expects to exceed 2022 revenue target with strong momentum to deliver continued growth in 2023 combining GeneDx and Centrellis ® platforms Company’s common stock will trade on the Nasdaq under new ticker “WGS” effective January 10, 2023 STAMFO...
STAMFORD, Conn., Dec. 30, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, today announced the company will participate in the 41 st Annual J.P. Morgan Healthcare Conference in San Francisco. Katherine Stueland , President and Chief Executive Officer, will del...
STAMFORD, Conn., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, today announced the results of a new study on mitochondrial diseases in newborns. The findings support the addition of mitochondrial DNA (mtDNA) testing to rapid exome sequencing, showing it ca...